Home
Directory
Destinations
Maps
DTCNews
Bookings
Español Español
  You are from:  Estados Unidos de America(select your country)
        My account   
Search
Bookings
+1 (833) 685-0373
Toll-Free

Lodging
Cars
Flights
Transfers
Packages
Open Voucher
Directory
Accommodation
Top list
Attractions
Where to shop
Embassies
General information
Marinas
Where to dine
Health
Transportation
Nightlife
TOOLS
Distancies calculator
Travelers' Tips
SUBSCRIPTIONS
DTCNews Subscription


We accept
We accept VISA and MasterCard credit cards.
Approved Site
Site powered by 3Milenio Reservation System

Weekly report on Cuba's tourism industry
Search in DTCNews 
  ReportsAttractions |  Services |  Destinations |  Culture |  Health |  General
  NewsTourism |  Business |  Health |  Sports |  Culture
HeberFERON Administered to Patients in Camagüey
Monday, August 3, 2020



Havana.- The health system in the eastern Cuban province of Camagüey resumed the use of HeberFERON, a medicine used against basal cell skin cancer.

The drug is administered at the Madame Curie Oncology and the Amalia Simoni Surgical Clinical hospitals.

Produced at the Genetic Engineering and Biotechnology Center (CIGB) in Havana, the drug has benefited 45 people in the territory.

The province shows favorable results with its administration, achieving approximately 74.5 percent of complete response to treatment in 2018 and 93.8 percent in 2019.

From 2017 to the end of last year, 136 therapeutic indications of mutilation of the nose and any of its areas, ears and eyes, on the eyelids and internal and external angles of the latter were prevented, thanks to the medication.



News
   HEADLINES

Home |  Directory | Destinations |  DTCNews | Flights | Lodging | Cars | Transfers | Open Voucher | Packages
About us | Terms and Conditions | Insurance Policy | Privacy Policy
(c) 1997-2024 Vacacionar Travel, SA. All rights reserved.